Logo image
Manipulating IL-10 signalling blockade for better immunotherapy
Journal article   Peer reviewed

Manipulating IL-10 signalling blockade for better immunotherapy

Guoying Ni, Tianfang Wang, Shelley F Walton, Bin Zhu, Shu Chen, Xiaolian Wu, Yuejian Wang, Ming Q Wei and Xiao Song Liu
Cellular Immunology, Vol.293(2), pp.126-129
2015
url
https://doi.org/10.1016/j.cellimm.2014.12.012View
Published Version

Abstract

interleukin 10 immunotherapy vaccine
Interleukin 10 is a cytokine with the ability to reduce or terminate inflammation. Chronic viral infection, such as infection of chronic hepatitis B, hepatitis C and HIV, has increased levels of interleukin 10 in peripheral blood. Serum IL-10 levels are also high in certain cancers. Blocking IL-10 signalling at the time of immunisation clears chronic viral infection and prevents tumour growth in animal models. We review recent advances in this area, with the emphasis on potential use of this novel strategy to treat chronic viral infection and cancer in human.

Details

Metrics

18 File views/ downloads
1009 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Web Of Science research areas
Cell Biology
Immunology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

Source: InCites

Logo image